Stronger Together Psoriatic Arthritis Wellness Study

Psoriatic Arthritis Clinical Trial

Official title:

Stronger Together Psoriatic Arthritis Wellness Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05652608
• Other study ID #: Pro00062932
• Status: Recruiting
• Start date: March 1, 2022
• Est. completion date: March 1, 2023

Study information

• Verified date: February 2023
• Source: Global Healthy Living Foundation
• Contact: W. Benjamin Nowell, Phd
• Phone: (845) 348 0400
• Email: bnowell[@]ghlf.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients diagnosed with psoriatic arthritis (PsA) confront decisions about how to treat their disease, interact with their health care providers, and modify lifestyle choices that may improve treatment outcomes. With sponsorship support from Janssen and in partnership with the Cleveland Clinic, this survey study will seek to understand and examine whether people living with PsA are interested in and motivated to participate in wellness activities. This cross-sectional observational survey study will help researchers and clinicians to better understand what some of the barriers and facilitators experienced by patients are when considering participation in guided online wellness activities.

People that qualify for the study and complete a 10-minute survey will be invited to participate in Immune Strength, an online wellness program developed by the Cleveland Clinic. Immune Strength is a free 10-week program for creating better habits for a more resilient immune system. By following this program, participants will have the opportunity to learn about how to develop strategies and implement behavior changes for healthier immune functioning.

Participants will be recruited by the Global Healthy Living Foundation (GHLF). GHLF is the parent organization of the CreakyJoints® (CJ) arthritis patient community and primary site for the PCORI-funded Arthritis Patient Partnership with Comparative Effectiveness Researchers (AR-PoWER) Patient Powered Research Network (PPRN), known as ArthritisPower®. ArthritisPower is a subset of CreakyJoints members who have expressed interest in participating in research and signed an informed consent form to participate in the PPRN and its associated research. Any individuals recruited from CreakyJoints or Facebook, who are not already members of ArthritisPower will be encouraged to join the ArthritisPower registry research app, but will not be required to do so in order to participate in the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: March 1, 2023
• Est. primary completion date: March 1, 2023
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Participants must be residents of the United States and United States territories

• Participants must be age 19 and above for United States resident or 21 and above for Puerto Rico residents

• Participants must have a self-reported diagnosis of psoriatic arthritis (PsA) (as indicated by survey screening questions)

• Participants must be taking prescribed medication to treat their PsA

• Participants must have access to a computer or smartphone to take the survey

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Psoriatic
• Psoriatic Arthritis

Intervention

Behavioral:
• Immune Strength
Multi-week wellness program provided by the Cleveland Clinic

Locations

Country	Name	City	State
United States	Global Healthy Living Foundation	Upper Nyack	New York

Sponsors (2)

Lead Sponsor	Collaborator
Global Healthy Living Foundation	The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Interest in Wellness Programs	Percent of participants interested in participating in a wellness program to complement treatment for controlling their disease	Day 1
Primary	Barriers to Wellness	Percent of participants that experience barriers in using wellness to help manage their disease	Day 1